In 2003, the spread of SARS brought opportunities for China's health product industry, which was in recession for years. Anything that can improve health conditions represented hot selling, even out of stock. Sales revenue of health product industry increased to £¤30 billion yuan in 2003 from £¤20 billion yuan in 2002, up by 50 percent; More important, consumers¡¯ consciousness of health care has been wakened. Along with ¡°Health Food Association of China (HFAC)¡± was canceled and ¡°China Health Technology Association¡± changed to ¡°China Health Care Association¡±, consumers more trust in health products.

Amway achieved prominent sales performance in China in 2003, with annual sales revenue of £¤4.2 billion yuan. Meanwhile, due to the forthcoming of China's direct-selling law, Nuskin indicated  itself would enter into Chinese health product market, challenge Amway directly.

Based on the statistics from National Statistic Bureau, China Health Product Association, China Economic Information Center, China Commercial Information Center, China Medical Healthcare Association, China Economic Monitoring Center, Ministry of Health and other 500 newspapers and magazines, the report presents an in-depth analysis on China's health product sector and its segmented markets, consumption status and competition pattern; it also presents a forecast on China's health product development trends.

1.Definition and classification of health products

2.Development of China's health product sector 
2.1 Three upgrading periods  
2.2 Six development stages 
2.3 Market status
2.4 Analysis on major economic indicators 
2.5 Retrospect of year 2003 
2.6 Prospects of health product sector

Part 2 Development status of global health product industry

3.Development summary of global health product industry

4.Development of the health product industry in major countries/regions

5.Development trends of global health product industry

6.R&D analysis 

Part 3 Market segmentation analysis of China's health product industry 

7.Calcium products 
7.1 Markey summary
7.2 Consumer analysis
7.3 Competitive pattern 
7.4 Wyeth-Whitehall Pharmaceutical Co., Ltd.
7.5 Shenzhen Neptunus Bioengineering Co., Ltd
7.6 Harbin Pharm. Group sixth 
7.7 Beijing Jinde
7.8 Harbin Pharm. Group Sanjing Pharmaceutical Co., Ltd.
7.9 Gaitianli 
7.10 Jiansu Longniqi Group Co., Ltd

8.Vitamin products 
8.1 Market development
8.2 Consumer analysis
8.3 Hangzhou Minsheng Pharmaceutical Group Co., Ltd.
8.4 Shanghai Goldpartner Biotech Co,. Ltd
8.5 Shanghai Squibb
8.6 Latest developments
8.7 Forecasts 

9.weight-losing products
9.1 Summary
9.2 Market status in the last 2 years
9.3 Consumer analysis 
9.4 Problems
9.5 Competition analysis 
9.6 Qumei Co., Ltd
9.7 Nanjing Changao Co., Ltd
9.8 Shantou Dayinxiang Co., Ltd
9.9 Prospects

10.Anti-aging products 
10.1 Consumer analysis
10.2 Competition analysis 
10.3 Jiankangyuan Group Co., Ltd
10.4 Yunnan Yunhai Group Co., Ltd
10.5 Guangzhou Yipintang Biotech Co., Ltd
10.6 Prospects

11.Products for enrichment of brain products
11.1 Summary
11.2 Market characteristics
11.3 HK Kangful International Co., Ltd
11.4 Naolingtong
12.Products for enrichment of Blood
12.1 Summary of the market development
12.2 Competition analysis 
12.3 Dong' E Ejiao Group Co., Ltd
12.4 Investment suggestions

13.Products for enrichment of Digestion & Stomach 
13.1 Market development
13.2 Consumer analysis
13.3 Shanghai Jiao Da Onlly Co., Ltd.

14.Immunity products
14.1 Market status
14.2 Ginseng market
14.3 Shenzhen Wanji Pharmaceutical Co., Ltd.

Part 4. Sizeable enterprises 

15.Chinese sizeable leading enterprises
15.1 Qindao Jiante BiotechCo., Ltd
15.2 Chengqing Taiji Group

16.Global sizeable leading enterprises
16.1 Amway America
16.2 Amway China
16.3 Roche Group
16.4 Roche China

Part 5. Marketing strategy of major brands

17.Review on the marketing strategies of major brands
17.1 Taiyangshen
17.2 Sanzhu
17.3 Naobaijin
17.4 Hongtao K

18.Marketing strategies of health product industry in China
18.1 Concept strategy
18.2 Ads Strategy
18.3 Brand strategy

19.Successful cases
19.1 Naobaijin
19.2 Alashancongrong

Part 6. Trends and investment suggestions

20.Development trends of China's health product industry
20.1 Nutrition status of Chinese people
20.2 Development of internal factors 
20.3 Development of external factors 
20.4 Prospects
20.5 Forecasts on the demand

21.Investment analysis of China's health product industry
21.1 SWOT analysis
21.2 Recommendations on the investment orientation
21.3 Market strategy
21.4 Successful service marketing modes
21.5 Marketing development trends
21.6 Position and problems of conference marketing